More on INBX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.6 Score)

Upcoming Events

- Earnings (11/13/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Inhibrx Inc. (NQ:INBX)
Delayed: 111.40 -0.02 (0.02%)
Prev. Close $111.42  
Open$113.00 
52 Wk High$ 
52 Wk Low$ 
Day High$115.11 
Day Low$109.22 
P/E N/A  
EPS$ 
Volume120,506 


Sep 11, 2026 01:16 PM Form 144 Inhibrx Biosciences, Filed by: MANHARD KIMBERLY
Sep 10, 2026 07:06 PM Form 4 Inhibrx Biosciences, For: Sep 08 Filed by: MANHARD KIMBERLY
Sep 9, 2026 07:30 AM H.C. Wainwright Reiterates Buy Rating on Inhibrx Biosciences (INBX)
Sep 8, 2026 07:41 AM Inhibrx drug INBRX-106 shows higher response rate in head and neck cancer
Aug 27, 2026 04:32 AM Inhibrx Biosciences (INBX) Reiterated at Market Perform by Citizens as Ozekibart Ph1 Started
Aug 24, 2026 06:07 AM H.C. Wainwright Starts Inhibrx Biosciences (INBX) at Buy
Aug 21, 2026 07:46 AM Inhibrx Biosciences (INBX) Reiterated at Buy by Stifel After Meet with CEO, CFO
Aug 14, 2026 05:23 PM Form SCHEDULE 13G/A Inhibrx Biosciences, Filed by: PERCEPTIVE ADVISORS LLC
Aug 14, 2026 04:22 PM Form SCHEDULE 13G Inhibrx Biosciences, Filed by: Schonfeld Strategic Advisors LLC
Aug 14, 2026 04:18 PM Form SCHEDULE 13G/A Inhibrx Biosciences, Filed by: VIKING GLOBAL INVESTORS LP
View All Articles

Entities mentioned with INBX

View All Entities